FOR US HEALTHCARE PROFESSIONALS ONLY

The safety and tolerability of INVEGA TRINZA^® were comparable to that of INVEGA SUSTENNA®¹

Evaluated in a long-term maintenance study and noninferiority study

Weight change, glucose levels, and lipid data evaluated in a long-term maintenance study

Incidence of extrapyramidal symptoms evaluated in a long-term maintenance study

Change in prolactin levels evaluated in an open-label study

Reference: 1. INVEGA TRINZA^® [Prescribing Information]. Titusville, NJ: Janssen Pharmaceuticals, Inc.

The safety and tolerability of INVEGA TRINZA® were comparable to that of INVEGA SUSTENNA®1